Owlet, Inc. (NYSE: OWLT) Stock Competitors & Peer Comparison
See OWLT's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for OWLT and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OWLT | $4.17 | -1.65% | 121.6M | -29.71 | -$0.14 | N/A |
| ABT | $109.93 | -3.23% | 190.3B | 21.10 | $5.21 | +2.28% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $101.80 | -2.90% | 130.2B | 18.41 | $5.53 | +2.81% |
| SYK | $325.87 | -2.75% | 124.1B | 24.34 | $13.39 | +1.09% |
| BSX | $42.75 | -4.23% | 62B | 13.79 | $3.10 | N/A |
| EW | $102.14 | +1.31% | 58.9B | 37.82 | $2.70 | N/A |
| GEHC | $82.38 | -1.64% | 37.2B | 16.81 | $4.90 | +0.18% |
| PHG | $30.35 | -0.52% | 29.7B | 17.34 | $1.75 | +3.27% |
| DXCM | $79.41 | -5.98% | 29.6B | 31.14 | $2.55 | N/A |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
OWLT vs ABT Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ABT has a market cap of 190.3B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ABT trades at $109.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ABT's P/E ratio is 21.10. In terms of profitability, OWLT's ROE is -0.50%, compared to ABT's ROE of +0.09%. Regarding short-term risk, OWLT is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
OWLT vs BSX-PA Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, OWLT's ROE is -0.50%, compared to BSX-PA's ROE of +0.14%. Regarding short-term risk, OWLT is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BSX-PA's competition here
Medtronic Plc (NYSE: MDT)
OWLT vs MDT Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, MDT has a market cap of 130.2B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while MDT trades at $101.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas MDT's P/E ratio is 18.41. In terms of profitability, OWLT's ROE is -0.50%, compared to MDT's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
OWLT vs SYK Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, SYK has a market cap of 124.1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while SYK trades at $325.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas SYK's P/E ratio is 24.34. In terms of profitability, OWLT's ROE is -0.50%, compared to SYK's ROE of +0.16%. Regarding short-term risk, OWLT is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
OWLT vs BSX Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, BSX has a market cap of 62B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while BSX trades at $42.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas BSX's P/E ratio is 13.79. In terms of profitability, OWLT's ROE is -0.50%, compared to BSX's ROE of +0.14%. Regarding short-term risk, OWLT is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
OWLT vs EW Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, EW has a market cap of 58.9B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while EW trades at $102.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas EW's P/E ratio is 37.82. In terms of profitability, OWLT's ROE is -0.50%, compared to EW's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check EW's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
OWLT vs GEHC Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, GEHC has a market cap of 37.2B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while GEHC trades at $82.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas GEHC's P/E ratio is 16.81. In terms of profitability, OWLT's ROE is -0.50%, compared to GEHC's ROE of +0.16%. Regarding short-term risk, OWLT is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
OWLT vs PHG Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, PHG has a market cap of 29.7B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while PHG trades at $30.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas PHG's P/E ratio is 17.34. In terms of profitability, OWLT's ROE is -0.50%, compared to PHG's ROE of +0.08%. Regarding short-term risk, OWLT is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PHG's competition here
DexCom, Inc. (NASDAQ: DXCM)
OWLT vs DXCM Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, DXCM has a market cap of 29.6B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while DXCM trades at $79.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas DXCM's P/E ratio is 31.14. In terms of profitability, OWLT's ROE is -0.50%, compared to DXCM's ROE of +0.37%. Regarding short-term risk, OWLT is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check DXCM's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
OWLT vs ZBH Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ZBH has a market cap of 20.1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ZBH trades at $105.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ZBH's P/E ratio is 12.45. In terms of profitability, OWLT's ROE is -0.50%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, OWLT is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
OWLT vs ABMD Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ABMD's P/E ratio is 65.36. In terms of profitability, OWLT's ROE is -0.50%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ABMD's competition here
Glaukos Corporation (NYSE: GKOS)
OWLT vs GKOS Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, GKOS has a market cap of 13.3B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while GKOS trades at $224.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas GKOS's P/E ratio is -260.83. In terms of profitability, OWLT's ROE is -0.50%, compared to GKOS's ROE of -0.25%. Regarding short-term risk, OWLT is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check GKOS's competition here
Smith & Nephew plc (NYSE: SNN)
OWLT vs SNN Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, SNN has a market cap of 13.1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while SNN trades at $31.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas SNN's P/E ratio is 21.03. In terms of profitability, OWLT's ROE is -0.50%, compared to SNN's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SNN's competition here
Penumbra, Inc. (NYSE: PEN)
OWLT vs PEN Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while PEN trades at $319.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas PEN's P/E ratio is 83.37. In terms of profitability, OWLT's ROE is -0.50%, compared to PEN's ROE of +0.10%. Regarding short-term risk, OWLT is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
OWLT vs SWAV Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas SWAV's P/E ratio is 78.76. In terms of profitability, OWLT's ROE is -0.50%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, OWLT is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
OWLT vs ALGN Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ALGN has a market cap of 11.8B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ALGN trades at $166.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ALGN's P/E ratio is 15.14. In terms of profitability, OWLT's ROE is -0.50%, compared to ALGN's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
OWLT vs BIO Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while BIO trades at $381.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas BIO's P/E ratio is 41.12. In terms of profitability, OWLT's ROE is -0.50%, compared to BIO's ROE of +0.14%. Regarding short-term risk, OWLT is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BIO's competition here
Insulet Corp. (NASDAQ: PODD)
OWLT vs PODD Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, PODD has a market cap of 10.2B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while PODD trades at $146.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas PODD's P/E ratio is 24.96. In terms of profitability, OWLT's ROE is -0.50%, compared to PODD's ROE of +0.29%. Regarding short-term risk, OWLT is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
OWLT vs BIO-B Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, BIO-B has a market cap of 9.9B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while BIO-B trades at $374.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas BIO-B's P/E ratio is -65.97. In terms of profitability, OWLT's ROE is -0.50%, compared to BIO-B's ROE of +0.14%. Regarding short-term risk, OWLT is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BIO-B's competition here
Globus Medical, Inc. (NYSE: GMED)
OWLT vs GMED Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, GMED has a market cap of 9.5B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while GMED trades at $71.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas GMED's P/E ratio is 16.00. In terms of profitability, OWLT's ROE is -0.50%, compared to GMED's ROE of +0.12%. Regarding short-term risk, OWLT is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check GMED's competition here
Masimo Corporation (NASDAQ: MASI)
OWLT vs MASI Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas MASI's P/E ratio is 44.43. In terms of profitability, OWLT's ROE is -0.50%, compared to MASI's ROE of +0.09%. Regarding short-term risk, OWLT is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
OWLT vs BRKR Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, BRKR has a market cap of 9.3B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while BRKR trades at $61.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas BRKR's P/E ratio is 30.81. In terms of profitability, OWLT's ROE is -0.50%, compared to BRKR's ROE of -0.05%. Regarding short-term risk, OWLT is more volatile compared to BRKR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
OWLT vs BRKRP Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, BRKRP has a market cap of 9.3B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while BRKRP trades at $446.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas BRKRP's P/E ratio is 244.34. In terms of profitability, OWLT's ROE is -0.50%, compared to BRKRP's ROE of -0.05%. Regarding short-term risk, OWLT is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
OWLT vs HAE Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, HAE has a market cap of 5.5B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while HAE trades at $119.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas HAE's P/E ratio is 23.93. In terms of profitability, OWLT's ROE is -0.50%, compared to HAE's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
OWLT vs LIVN Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, LIVN has a market cap of 4.9B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while LIVN trades at $89.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas LIVN's P/E ratio is 21.37. In terms of profitability, OWLT's ROE is -0.50%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, OWLT is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check LIVN's competition here
Inari Medical, Inc. (NASDAQ: NARI)
OWLT vs NARI Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas NARI's P/E ratio is -59.24. In terms of profitability, OWLT's ROE is -0.50%, compared to NARI's ROE of -0.00%. Regarding short-term risk, OWLT is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
OWLT vs ITGR Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ITGR trades at $126.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ITGR's P/E ratio is 19.94. In terms of profitability, OWLT's ROE is -0.50%, compared to ITGR's ROE of +0.06%. Regarding short-term risk, OWLT is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ITGR's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
OWLT vs TMDX Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while TMDX trades at $88.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas TMDX's P/E ratio is 44.77. In terms of profitability, OWLT's ROE is -0.50%, compared to TMDX's ROE of +0.28%. Regarding short-term risk, OWLT is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
OWLT vs AXGN Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, AXGN has a market cap of 3B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while AXGN trades at $50.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas AXGN's P/E ratio is 131.53. In terms of profitability, OWLT's ROE is -0.50%, compared to AXGN's ROE of -0.11%. Regarding short-term risk, OWLT is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AXGN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
OWLT vs IRTC Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, IRTC has a market cap of 3B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while IRTC trades at $90.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas IRTC's P/E ratio is -209.53. In terms of profitability, OWLT's ROE is -0.50%, compared to IRTC's ROE of -0.23%. Regarding short-term risk, OWLT is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
OWLT vs NEOG Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while NEOG trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas NEOG's P/E ratio is 42.00. In terms of profitability, OWLT's ROE is -0.50%, compared to NEOG's ROE of -0.03%. Regarding short-term risk, OWLT is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
OWLT vs UFPT Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while UFPT trades at $303.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas UFPT's P/E ratio is 30.94. In terms of profitability, OWLT's ROE is -0.50%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, OWLT is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
OWLT vs NUVA Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas NUVA's P/E ratio is 75.00. In terms of profitability, OWLT's ROE is -0.50%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, OWLT is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
OWLT vs ESTA Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ESTA trades at $67.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ESTA's P/E ratio is -53.24. In terms of profitability, OWLT's ROE is -0.50%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, OWLT is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check ESTA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
OWLT vs INSP Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, INSP has a market cap of 1.9B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while INSP trades at $63.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas INSP's P/E ratio is 28.18. In terms of profitability, OWLT's ROE is -0.50%, compared to INSP's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check INSP's competition here
Butterfly Network, Inc. (NYSE: BFLY)
OWLT vs BFLY Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, BFLY has a market cap of 1.7B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while BFLY trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas BFLY's P/E ratio is -26.52. In terms of profitability, OWLT's ROE is -0.50%, compared to BFLY's ROE of -0.28%. Regarding short-term risk, OWLT is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BFLY's competition here
Enovis Corporation (NYSE: ENOV)
OWLT vs ENOV Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ENOV has a market cap of 1.6B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ENOV trades at $27.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ENOV's P/E ratio is 7.77. In terms of profitability, OWLT's ROE is -0.50%, compared to ENOV's ROE of -0.36%. Regarding short-term risk, OWLT is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ENOV's competition here
Novocure Ltd (NASDAQ: NVCR)
OWLT vs NVCR Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, NVCR has a market cap of 1.6B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while NVCR trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas NVCR's P/E ratio is -12.52. In terms of profitability, OWLT's ROE is -0.50%, compared to NVCR's ROE of -0.36%. Regarding short-term risk, OWLT is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NVCR's competition here
CONMED Corporation (NYSE: CNMD)
OWLT vs CNMD Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while CNMD trades at $51.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas CNMD's P/E ratio is 11.32. In terms of profitability, OWLT's ROE is -0.50%, compared to CNMD's ROE of +0.07%. Regarding short-term risk, OWLT is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
OWLT vs HSKA Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas HSKA's P/E ratio is -62.49. In terms of profitability, OWLT's ROE is -0.50%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, OWLT is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check HSKA's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
OWLT vs LMRI Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, LMRI has a market cap of 1.3B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while LMRI trades at $13.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas LMRI's P/E ratio is -26.07. In terms of profitability, OWLT's ROE is -0.50%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, OWLT is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check LMRI's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
OWLT vs TNDM Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while TNDM trades at $16.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas TNDM's P/E ratio is -18.18. In terms of profitability, OWLT's ROE is -0.50%, compared to TNDM's ROE of -0.36%. Regarding short-term risk, OWLT is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check TNDM's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
OWLT vs PRCT Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while PRCT trades at $20.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas PRCT's P/E ratio is -10.62. In terms of profitability, OWLT's ROE is -0.50%, compared to PRCT's ROE of -0.33%. Regarding short-term risk, OWLT is more volatile compared to PRCT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
OWLT vs AVNS Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas AVNS's P/E ratio is 27.77. In terms of profitability, OWLT's ROE is -0.50%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, OWLT is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AVNS's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
OWLT vs ATEC Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ATEC has a market cap of 1.2B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ATEC trades at $7.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ATEC's P/E ratio is -13.21. In terms of profitability, OWLT's ROE is -0.50%, compared to ATEC's ROE of -5.47%. Regarding short-term risk, OWLT is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ATEC's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
OWLT vs SILK Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas SILK's P/E ratio is -18.96. In terms of profitability, OWLT's ROE is -0.50%, compared to SILK's ROE of -0.35%. Regarding short-term risk, OWLT is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
OWLT vs FNA Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas FNA's P/E ratio is -19.83. In terms of profitability, OWLT's ROE is -0.50%, compared to FNA's ROE of -0.35%. Regarding short-term risk, OWLT is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
OWLT vs IRMD Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while IRMD trades at $86.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas IRMD's P/E ratio is 43.16. In terms of profitability, OWLT's ROE is -0.50%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, OWLT is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check IRMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
OWLT vs SIBN Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, SIBN has a market cap of 1.1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while SIBN trades at $24.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas SIBN's P/E ratio is -71.29. In terms of profitability, OWLT's ROE is -0.50%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, OWLT is more volatile compared to SIBN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SIBN's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
OWLT vs IART Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, IART has a market cap of 1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while IART trades at $13.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas IART's P/E ratio is 5.69. In terms of profitability, OWLT's ROE is -0.50%, compared to IART's ROE of +0.01%. Regarding short-term risk, OWLT is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check IART's competition here
CeriBell, Inc. (NASDAQ: CBLL)
OWLT vs CBLL Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, CBLL has a market cap of 1B. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while CBLL trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas CBLL's P/E ratio is -15.12. In terms of profitability, OWLT's ROE is -0.50%, compared to CBLL's ROE of -0.55%. Regarding short-term risk, OWLT is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check CBLL's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
OWLT vs AHCO Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, AHCO has a market cap of 998.7M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while AHCO trades at $7.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas AHCO's P/E ratio is 14.95. In terms of profitability, OWLT's ROE is -0.50%, compared to AHCO's ROE of -0.29%. Regarding short-term risk, OWLT is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AHCO's competition here
Artivion, Inc. (NYSE: AORT)
OWLT vs AORT Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, AORT has a market cap of 985.1M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while AORT trades at $20.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas AORT's P/E ratio is 33.67. In terms of profitability, OWLT's ROE is -0.50%, compared to AORT's ROE of -0.04%. Regarding short-term risk, OWLT is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check AORT's competition here
Picard Medical, Inc. (AMEX: PMI)
OWLT vs PMI Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, PMI has a market cap of 877.7M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while PMI trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas PMI's P/E ratio is -7.12. In terms of profitability, OWLT's ROE is -0.50%, compared to PMI's ROE of -9.31%. Regarding short-term risk, OWLT is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check PMI's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
OWLT vs CSII Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas CSII's P/E ratio is -20.83. In terms of profitability, OWLT's ROE is -0.50%, compared to CSII's ROE of -0.14%. Regarding short-term risk, OWLT is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CSII's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
OWLT vs KIDS Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, KIDS has a market cap of 829.5M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while KIDS trades at $31.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas KIDS's P/E ratio is -23.71. In terms of profitability, OWLT's ROE is -0.50%, compared to KIDS's ROE of -0.10%. Regarding short-term risk, OWLT is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check KIDS's competition here
Varex Imaging Corporation (NASDAQ: VREX)
OWLT vs VREX Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, VREX has a market cap of 783.4M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while VREX trades at $18.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas VREX's P/E ratio is 19.42. In terms of profitability, OWLT's ROE is -0.50%, compared to VREX's ROE of +0.05%. Regarding short-term risk, OWLT is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check VREX's competition here
InMode Ltd. (NASDAQ: INMD)
OWLT vs INMD Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, INMD has a market cap of 767.6M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while INMD trades at $13.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas INMD's P/E ratio is 9.26. In terms of profitability, OWLT's ROE is -0.50%, compared to INMD's ROE of +0.12%. Regarding short-term risk, OWLT is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check INMD's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
OWLT vs CTKB Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, CTKB has a market cap of 760.4M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while CTKB trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas CTKB's P/E ratio is -30.99. In terms of profitability, OWLT's ROE is -0.50%, compared to CTKB's ROE of -0.25%. Regarding short-term risk, OWLT is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check CTKB's competition here
Bioventus Inc. (NASDAQ: BVS)
OWLT vs BVS Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, BVS has a market cap of 725.1M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while BVS trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas BVS's P/E ratio is 13.93. In terms of profitability, OWLT's ROE is -0.50%, compared to BVS's ROE of +0.27%. Regarding short-term risk, OWLT is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check BVS's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
OWLT vs BBNX Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, BBNX has a market cap of 706.8M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while BBNX trades at $15.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas BBNX's P/E ratio is -8.54. In terms of profitability, OWLT's ROE is -0.50%, compared to BBNX's ROE of -0.27%. Regarding short-term risk, OWLT is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check BBNX's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
OWLT vs PACB Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, PACB has a market cap of 700.9M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while PACB trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas PACB's P/E ratio is -5.50. In terms of profitability, OWLT's ROE is -0.50%, compared to PACB's ROE of +6.04%. Regarding short-term risk, OWLT is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check PACB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
OWLT vs SRDX Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas SRDX's P/E ratio is -34.66. In terms of profitability, OWLT's ROE is -0.50%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, OWLT is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SRDX's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
OWLT vs TCMD Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, TCMD has a market cap of 583.1M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while TCMD trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas TCMD's P/E ratio is 24.10. In terms of profitability, OWLT's ROE is -0.50%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, OWLT is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check TCMD's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
OWLT vs APEN Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas APEN's P/E ratio is -9.43. In terms of profitability, OWLT's ROE is -0.50%, compared to APEN's ROE of -0.85%. Regarding short-term risk, OWLT is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check APEN's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
OWLT vs SGHT Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, SGHT has a market cap of 556.4M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while SGHT trades at $10.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas SGHT's P/E ratio is -18.04. In terms of profitability, OWLT's ROE is -0.50%, compared to SGHT's ROE of -0.52%. Regarding short-term risk, OWLT is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check SGHT's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
OWLT vs AVR Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, AVR has a market cap of 554.1M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while AVR trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas AVR's P/E ratio is -2.93. In terms of profitability, OWLT's ROE is -0.50%, compared to AVR's ROE of -0.78%. Regarding short-term risk, OWLT is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check AVR's competition here
ZimVie Inc. (NASDAQ: ZIMV)
OWLT vs ZIMV Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, OWLT's ROE is -0.50%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, OWLT is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ZIMV's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
OWLT vs DCTH Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, DCTH has a market cap of 518.4M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while DCTH trades at $14.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas DCTH's P/E ratio is 1494.00. In terms of profitability, OWLT's ROE is -0.50%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, OWLT is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check DCTH's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
OWLT vs SENS Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, SENS has a market cap of 453.7M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while SENS trades at $8.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas SENS's P/E ratio is -3.85. In terms of profitability, OWLT's ROE is -0.50%, compared to SENS's ROE of -1.66%. Regarding short-term risk, OWLT is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check SENS's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
OWLT vs SSII Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, SSII has a market cap of 430M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while SSII trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas SSII's P/E ratio is -35.75. In terms of profitability, OWLT's ROE is -0.50%, compared to SSII's ROE of -0.27%. Regarding short-term risk, OWLT is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check SSII's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
OWLT vs NPCE Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, NPCE has a market cap of 428.4M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while NPCE trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas NPCE's P/E ratio is -21.89. In terms of profitability, OWLT's ROE is -0.50%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, OWLT is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NPCE's competition here
Avita Medical Inc. (NASDAQ: RCEL)
OWLT vs RCEL Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, RCEL has a market cap of 412.4M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while RCEL trades at $16.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas RCEL's P/E ratio is -11.53. In terms of profitability, OWLT's ROE is -0.50%, compared to RCEL's ROE of +1.46%. Regarding short-term risk, OWLT is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check RCEL's competition here
Cerus Corporation (NASDAQ: CERS)
OWLT vs CERS Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, CERS has a market cap of 406.9M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while CERS trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas CERS's P/E ratio is -66.94. In terms of profitability, OWLT's ROE is -0.50%, compared to CERS's ROE of -0.11%. Regarding short-term risk, OWLT is more volatile compared to CERS. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CERS's competition here
CapsoVision, Inc. (NASDAQ: CV)
OWLT vs CV Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, CV has a market cap of 336M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while CV trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas CV's P/E ratio is -10.02. In terms of profitability, OWLT's ROE is -0.50%, compared to CV's ROE of -1.78%. Regarding short-term risk, OWLT is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CV's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
OWLT vs OFIX Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, OFIX has a market cap of 317.9M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while OFIX trades at $7.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas OFIX's P/E ratio is -5.12. In terms of profitability, OWLT's ROE is -0.50%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, OWLT is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check OFIX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
OWLT vs SMLR Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas SMLR's P/E ratio is 3.92. In terms of profitability, OWLT's ROE is -0.50%, compared to SMLR's ROE of +0.20%. Regarding short-term risk, OWLT is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check SMLR's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
OWLT vs CLPT Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, CLPT has a market cap of 275.5M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while CLPT trades at $8.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas CLPT's P/E ratio is -7.28. In terms of profitability, OWLT's ROE is -0.50%, compared to CLPT's ROE of -1.70%. Regarding short-term risk, OWLT is more volatile compared to CLPT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check CLPT's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
OWLT vs INFU Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, INFU has a market cap of 273.5M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while INFU trades at $13.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas INFU's P/E ratio is 33.49. In terms of profitability, OWLT's ROE is -0.50%, compared to INFU's ROE of +0.16%. Regarding short-term risk, OWLT is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check INFU's competition here
Profound Medical Corp. (NASDAQ: PROF)
OWLT vs PROF Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, PROF has a market cap of 263.8M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while PROF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas PROF's P/E ratio is -7.37. In terms of profitability, OWLT's ROE is -0.50%, compared to PROF's ROE of -0.28%. Regarding short-term risk, OWLT is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check PROF's competition here
Quantum-Si incorporated (NASDAQ: QSI)
OWLT vs QSI Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, QSI has a market cap of 263.6M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while QSI trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas QSI's P/E ratio is -2.88. In terms of profitability, OWLT's ROE is -0.50%, compared to QSI's ROE of -0.45%. Regarding short-term risk, OWLT is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check QSI's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
OWLT vs TMCI Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, TMCI has a market cap of 262.7M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while TMCI trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas TMCI's P/E ratio is -4.30. In terms of profitability, OWLT's ROE is -0.50%, compared to TMCI's ROE of -0.76%. Regarding short-term risk, OWLT is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check TMCI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
OWLT vs MGRM Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas MGRM's P/E ratio is -12.00. In terms of profitability, OWLT's ROE is -0.50%, compared to MGRM's ROE of -1.17%. Regarding short-term risk, OWLT is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check MGRM's competition here
Nevro Corp. (NYSE: NVRO)
OWLT vs NVRO Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas NVRO's P/E ratio is -1.91. In terms of profitability, OWLT's ROE is -0.50%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, OWLT is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check NVRO's competition here
Electromed, Inc. (AMEX: ELMD)
OWLT vs ELMD Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ELMD has a market cap of 223.4M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ELMD trades at $27.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ELMD's P/E ratio is 20.58. In terms of profitability, OWLT's ROE is -0.50%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, OWLT is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
OWLT vs TLSI Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, TLSI has a market cap of 199.5M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while TLSI trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas TLSI's P/E ratio is -1.93. In terms of profitability, OWLT's ROE is -0.50%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, OWLT is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check TLSI's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
OWLT vs BSGM Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas BSGM's P/E ratio is -5.81. In terms of profitability, OWLT's ROE is -0.50%, compared to BSGM's ROE of +6.96%. Regarding short-term risk, OWLT is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check BSGM's competition here
RxSight, Inc. (NASDAQ: RXST)
OWLT vs RXST Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, RXST has a market cap of 188.6M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while RXST trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas RXST's P/E ratio is -4.01. In terms of profitability, OWLT's ROE is -0.50%, compared to RXST's ROE of -0.20%. Regarding short-term risk, OWLT is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check RXST's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
OWLT vs MDGS Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas MDGS's P/E ratio is -0.27. In terms of profitability, OWLT's ROE is -0.50%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, OWLT is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
OWLT vs STIM Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, STIM has a market cap of 163.4M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while STIM trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas STIM's P/E ratio is -4.87. In terms of profitability, OWLT's ROE is -0.50%, compared to STIM's ROE of -1.28%. Regarding short-term risk, OWLT is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check STIM's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
OWLT vs QIPT Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas QIPT's P/E ratio is -15.87. In terms of profitability, OWLT's ROE is -0.50%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, OWLT is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
OWLT vs INGN Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, INGN has a market cap of 160M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while INGN trades at $6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas INGN's P/E ratio is -6.63. In terms of profitability, OWLT's ROE is -0.50%, compared to INGN's ROE of -0.20%. Regarding short-term risk, OWLT is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
OWLT vs QTRX Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, QTRX has a market cap of 137.1M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while QTRX trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas QTRX's P/E ratio is -1.14. In terms of profitability, OWLT's ROE is -0.50%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, OWLT is more volatile compared to QTRX. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check QTRX's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
OWLT vs FOCL Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, FOCL has a market cap of 125.9M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while FOCL trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas FOCL's P/E ratio is -3.25. In terms of profitability, OWLT's ROE is -0.50%, compared to FOCL's ROE of -2.41%. Regarding short-term risk, OWLT is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check FOCL's competition here
Pulmonx Corporation (NASDAQ: LUNG)
OWLT vs LUNG Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, LUNG has a market cap of 109.9M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while LUNG trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas LUNG's P/E ratio is -2.53. In terms of profitability, OWLT's ROE is -0.50%, compared to LUNG's ROE of -0.98%. Regarding short-term risk, OWLT is less volatile compared to LUNG. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check LUNG's competition here
iCAD, Inc. (NASDAQ: ICAD)
OWLT vs ICAD Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ICAD's P/E ratio is -20.37. In terms of profitability, OWLT's ROE is -0.50%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, OWLT is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
OWLT vs HJLI Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas HJLI's P/E ratio is N/A. In terms of profitability, OWLT's ROE is -0.50%, compared to HJLI's ROE of -0.70%. Regarding short-term risk, OWLT is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check HJLI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
OWLT vs CATX Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, CATX has a market cap of 95.9M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while CATX trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas CATX's P/E ratio is -0.63. In terms of profitability, OWLT's ROE is -0.50%, compared to CATX's ROE of -0.42%. Regarding short-term risk, OWLT is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for OWLT.Check CATX's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
OWLT vs ASXC Comparison November 2026
Owlet, Inc. (NYSE: OWLT) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OWLT stands at 121.6M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, OWLT is priced at $4.17 on the NYSE, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OWLT currently has a P/E ratio of -29.71, whereas ASXC's P/E ratio is -1.12. In terms of profitability, OWLT's ROE is -0.50%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, OWLT is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for OWLT.Check ASXC's competition here